Gender differences in proenkephalin gene expression response to ∆9-tetrahydrocannabinol in the hypothalamus of the rat
- 1 July 2002
- journal article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 16 (4) , 283-289
- https://doi.org/10.1177/026988110201600401
Abstract
Chronic exposure to∆9-tetrahydrocannabinol (∆9-THC) produces an activation of preproenkephalin (PENK) gene expression in the rat hypothalamus. The levels of circulating gonadal steroids concurrently modulate this neuropeptide in male and female rats. However, whether gonadal steroids regulate ∆9-THC effects on PENK gene expression in the hypothalamus of male and female rats remains unknown. To test this hypothesis, experiments were carried out on intact, 2-week-gonadectomized, 1-week-gonadectomized, 1-week-dihydrotestosterone (DHT) replaced male rats, and 2-week-gonadectomized, 1-week-gonadectomized, 1-week-oestradiol replaced female rats. One week after hormonal replacement, animals were treated with vehicle or ∆9-THC (5 mg/kg/day, i.p. 7 days). In males, ∆9-THC administration to intact animals induced PENK mRNA in the paraventricular nucleus (PVN) and ventromedial nucleus (VMN) of the hypothalamus. Orchidectomy did not affect basal PENK mRNA levels in the PVN, but reduced PENK mRNA levels in the VMN. However, ∆9-THC treatment induced PENK gene expression to the same extent in both hypothalamic nuclei of intact, castrated and DHT-replaced males. In females, ovariectomy decreased PENK gene expression in PVN and VMN. ∆9-THC administration increased PENK gene expression in castrated females, but had no effect in the oestradiol-replaced group. Taken together, these results suggest gender differences in the response of chronic exposure to cannabinoids on PENK gene expression in the hypothalamus. Furthermore, it appears that alterations in opioid gene expression induced by cannabinoids in female rats depend upon the presence or absence of circulating oestradiol.Keywords
This publication has 42 references indexed in Scilit:
- Repeated administration of Δ9-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the ratNeuropharmacology, 1999
- Chronic treatment with CP-55,940 regulates corticotropin releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the ratLife Sciences, 1999
- Perinatal Δ9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female ratsLife Sciences, 1998
- Inhibition of opioid-degrading enzymes potentiates Δ9-tetrahydrocannabinol-induced antinociception in miceNeuropharmacology, 1998
- Δ-9-Tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the ratLife Sciences, 1997
- Estrogen and Stress Interact to Regulate the Hypothalamic Expression of a Human Proenkephalin Promoter‐β‐Galactosidase Fusion Gene in a Site‐Specific and Sex‐Specific MannerJournal of Neuroendocrinology, 1997
- Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphineNeuropharmacology, 1995
- Effects of chronic treatment with Δ-9-tetrahydrocannabinol on uterine growth in the mouseLife Sciences, 1994
- Effects of 9-ene-tetrahydrocannabinol on uterine estrogenicity in the mouseThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990